Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.20.24509
David Robinson, MD discusses an AJR pilot study exploring 18F-Fluciclovine PET/MRI for initial staging of prostate cancer and the effects of androgen deprivation therapy on 18F-Fluciclovine uptake.
